IP Library Granted Patent US 10,428,303
Granted Patent B2
US 10,428,303 · App. 14/327,503 · Granted Oct 1, 2019

Embryo culture methods and media

Inventors: Rebecca Gilbert (Irvine, CA); Hsiao-Tzu Ni (Irvine, CA); Suh-Fon Hwan (Shanghai, CN)
Assignee: FUJIFILM Irvine Scientific, Inc.
C12N5/0604A61B17/43C12N2500/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,428,303
App. No.
14/327,503
Granted
Oct 1, 2019
Kind
B2
Abstract

Improved methods of culturing embryos in media having amounts of lactate that have not previously been recognized as beneficial for embryo development. Also, compositions, devices and kits related to the same.

Claims (21)

1. A method of culturing a human embryo in vitro, the method comprising culturing a human embryo in a medium comprising: a starting lactate concentration of between about 0.3 mM and about 1 mM, and a glucose concentration of less than about 2 mM, wherein the medium does not contain serum, wherein the medium is a sequential medium or a medium that is replenished at least once during the culturing of the embryo.

2. The method of claim 1 , wherein the starting lactate concentration is about 1 mM.

3. The method of claim 1 , further comprising culturing the embryo in an incubator.

4. The method of claim 3 , wherein the incubator comprises an imaging system to capture one or more images of the embryo during culturing.

5. The method of claim 4 , wherein the one or more images can be captured without moving the embryo.

6. The method of claim 1 , wherein the medium is a modified version of any of the following: P-1 medium, G1 medium, G2 Medium, a Human Tubal Fluid (HTF) medium with or without glucose or phosphate, modified HTF medium, Whitten's Medium, Ham's F-10 Medium, or KSOM medium, with or without protein supplementation.

7. The method of claim 1 , wherein said embryo is from a patient suffering from infertility or undergoing fertility treatment.

8. The method of claim 1 , wherein said embryo is cultured for about 1 day to about 7 days.

9. The method of claim 8 , wherein the embryo is cultured for about 3 days to about 6 days.

10. The method of claim 9 , wherein the embryo is cultured until it reaches an 8-cell stage or a blastocyst stage.

11. The method of claim 1 , further comprising implanting said embryo into a female patient.

12. A composition for culturing a human embryo, comprising an embryo culture medium suitable for culturing a human embryo and that is modified to have:

(i) a lactate concentration of between about 0.3 mM and about 1 mM,

(ii) a glucose concentration of less than about 2 mM,

(iii) human serum albumin; and

wherein the embryo culture medium does not contain serum.

13. The method of claim 1 , wherein the medium further comprises human serum albumin.

14. The composition of claim 12 , wherein the lactate concentration is about 1 mM.

15. The composition of claim 12 , further comprising at least one additional energy substrate.

16. The composition of claim 15 , wherein the energy substrate is pyruvate.

17. The composition of claim 16 , wherein the pyruvate is present in the composition at a concentration of between about 0.1 mM to about 3 mM.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2025
From: FUJIFILM IRVINE SCIENTIFIC, INC.
To: NEXPRING US OPCO INC.
Reel/Frame 071448/0269 →
CHANGE OF NAME Recorded Aug 12, 2019
From: IRVINE SCIENTIFIC SALES COMPANY, INC.
To: FUJIFILM IRVINE SCIENTIFIC, INC.
Reel/Frame 050027/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: GILBERT, REBECCA; NI, HSIAO-TZU; HWAN, SUH-FON
To: IRVINE SCIENTIFIC SALES COMPANY, INC.
Reel/Frame 034178/0782 →
Continuity (2)
Provisional Application 61844345 · Jul 9, 2013
Related Publication 20150018605A1 · Jan 15, 2015